MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
Go back to MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures| MACROGENICS (NASDAQ: MGNX) | Delayed: 4.00 +0.03 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.97 | 52 Week High | $36.11 | |||
| Open | $4.02 | 52 Week Low | $14.84 | |||
| Day High | $4.09 | P/E | 10.26 | |||
| Day Low | $3.91 | EPS | $0.39 | |||
| Volume | 381,930 | |||||

